Use of Cetuximab in Combination with Cisplatin and Adjuvant Pelvic Radiation for Stage IIIB Vulvar Carcinoma

Vulvar cancer is a rare carcinoma constituting only 4% of gynecologic malignancies and 0.6% of female cancers. Most chemotherapy regimens have been created from extrapolation from anal and cervical cancer research. Advanced stages have the worst prognosis and oftentimes invasive surgical procedures...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergstrom, Jennifer, Bidus, Michael, Miles, Edward, Allard, Jay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532892/
https://www.ncbi.nlm.nih.gov/pubmed/26294988
http://dx.doi.org/10.1155/2015/139817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532892/
https://www.ncbi.nlm.nih.gov/pubmed/26294988
http://dx.doi.org/10.1155/2015/139817

Ejemplares similares